---

30 Oct 2006 : Column 164W—continued

30 Oct 2006 : Column 165W

30 Oct 2006 : Column 166W

BNF chemical name	1999	2000	2001	2002	2003	2004	2005
Acipimox	6.9	6.7	6.6	6.3	6.1	5.3	5.2
Atorvastatin	1,703.7	2,885.5	4,407.6	6,450.7	8,629.4	11,238.1	13,172.8
Bezafibrate	510.5	485.0	469.1	456.3	443.1	426.2	423.1
Cerivastatin	463.8	767.1	659.8	0.2	0.0	0.0	0.0
Chondroitin Sulphate A	—	—	—	—	—	—	—
Ciprofibrate	136.1	125.9	119.0	108.9	99.9	91.8	86.2
Clofibrate	12.4	2.9	0.0	0.0	—	—	—
Colestipol Hydrochloride	14.6	12.7	12.5	11.9	10.6	8.6	8.0
Colestyramine	67.3	69.3	71.9	74.8	74.8	73.7	73.4
Ezetimibe	—	—	—	—	50.1	293.2	661.0
Fenofibrate	106.5	127.5	164.8	204.4	239.9	272.7	307.2
Fluvastatin Sodium	315.6	395.0	581.1	783.7	774.5	671.7	515.8
Gemfibrozil	39.3	36.5	36.1	34.4	32.3	28.6	25.7
Ispaghula Husk	9.6	9.1	8.7	8.1	6.0	8.6	1.1
Lovastatin	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Nicofuranose	—	—	—	—	—	—	—
Nicotinic Acid	3.3	2.0	1.9	1.6	1.6	13.7	25.2
Omega-3 Marine	—	—	—	—	—	—	—
Triglycerides	29.5	30.2	31.7	33.5	32.1	32.8	35.1
Omega-3-Acid Ethyl Esters	—	—	—	0.8	22.7	78.7	145.0
Other Preparations	—	0.0	0.0	0.0	0.0	0.0	0.0
Pravastatin Sodium	0.0	1,200.4	1,684.1	2,292.4	2,582.3	2,503.9	2,217.9
Probucol	918.5	0.0	0.0	—	—	—	—
Rosuvastatin Calcium	0.0	—	—	—	277.4	1,015.8	1,311.8
Simvastatin	—	4,174.9	5,268.1	7,135.8	9,371.4	12,680.9	16,536.9
Simvastatin and Ezetimibe	3,588.0	—	—	—	—	—	16.4
Sitosterol	—	—	—	—	—	—	—
Notes: 1. Prescription costs analysis (PCA) data. Prescription information is taken from the PCA system, supplied by the prescription pricing division of the NHS Business Services Authority and is based on a full analysis of all prescriptions dispensed in the community i.e. by community pharmacists and appliance contractors, dispensing doctors, and prescriptions submitted by prescribing doctors for items personally administered in England. Also included are prescriptions written in Wales, Scotland, Northern Ireland and the Isle of Man but dispensed in England. The data do not cover drugs dispensed in hospitals, including mental health trusts, or private prescriptions. 2. Prescription items. Prescriptions are written on a prescription form. Each single item written on the form is counted as a prescription item. 3. Discontinuity of data. Please note that data up to 1990 have not been provided as they are not consistent with data from 1991 onwards. Figures for 1980 to 1990 are based on fees and on a sample of one in 200 prescriptions dispensed by community pharmacists and appliance contractors only. Figures for 1991 onwards are based on items and cover all prescriptions dispensed by community pharmacists, appliance contractors, dispensing doctors and prescriptions submitted by prescribing doctors for items personally administered. Source: PCA.

Community Hospitals

Mr. Graham Stuart: To ask the Secretary of State for Health whether primary care trusts will be required to launch a full public consultation before submitting bids for the £750 million of capital made available by her Department for community hospitals; and if she will make a statement. [93462]

Andy Burnham: When evaluating proposals for funding, the Department will expect to see evidence that primary care trusts have complied with their legal duty to involve and consult patients and the public.

The national health service has a duty under section 11 of the Health and Social Care Act 2001 to involve and consult patients and the public, not just when major change is proposed, but in the ongoing planning of services; not just when considering a proposal, but in developing that proposal; and in decisions that may affect the operation of services.

Continuing Healthcare

Mr. Kidney: To ask the Secretary of State for Health what changes she plans to make to NHS arrangements for continuing healthcare. [95378]

Mr. Ivan Lewis: We are in the process of introducing a national system for deciding who gets national health service funding for continuing care. Proposals for the national framework for continuing care were presented for public consultation for three months from 19 June 2006 to 22 September 2006. The proposals detail plans for a single, simplified and coherent system for eligibility and assessment of national health service funding—both for fully funded national health service continuing healthcare and national health service-funded nursing care. Responses to the consultation are currently being analysed with a view to publishing the Government’s response to the consultation in late 2006.

CSR 2007

Mr. Lansley: To ask the Secretary of State for Health what working groups have been established by her Department in order to inform her Department's input into the comprehensive spending review 2007; what topics the groups cover; what staff the groups have in support of their work; and if she will make a statement. [92035]

Andy Burnham: The work of the Department on the comprehensive spending review (CSR) is overseen at official level by a joint Department of Health and HM Treasury steering group, with consultation with the NHS management board and the social CSR review working group.

The Department of Health has analytical, finance and policy teams working on all areas of the CSR, including the following: trends in underlying demand and costs, value for money reviews, the approach to investment and asset management, pay and workforce,
30 Oct 2006 : Column 167W
and the performance framework. Departmental officials are also involved in the work on cross-Government policy reviews that will feed into the CSR, including the mental health and employment outcomes review and the supporting housing growth review.

---